BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND CLTC, CLTCL2, 1213, ENSG00000141367, Q00610
40 results:

  • 1. Open questions on lower urinary tract infections: Results of a Delphi consensus study.
    Iacovelli V; Ficarra V; Maestroni UV; Tutolo M; Finazzi Agrò E
    Neurourol Urodyn; 2024 Apr; 43(4):915-924. PubMed ID: 38213058
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study.
    Grande E; Arranz JÁ; De Santis M; Bamias A; Kikuchi E; Del Muro XG; Park SH; De Giorgi U; Alekseev B; Mencinger M; Izumi K; Schutz FA; Puente J; Li JR; O'Donnell PH; Kalebasty AR; Ye D; Mariathasan S; Bene-Tchaleu F; Bernhard S; Lee C; Davis ID; Galsky MD
    Lancet Oncol; 2024 Jan; 25(1):29-45. PubMed ID: 38101433
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study.
    Bamias A; Davis ID; Galsky MD; Arranz JÁ; Kikuchi E; Grande E; Del Muro XG; Park SH; De Giorgi U; Alekseev B; Mencinger M; Izumi K; Schutz FA; Puente J; Li JR; Panni S; Gumus M; Özgüroğlu M; Mariathasan S; Poloz Y; Bene-Tchaleu F; Lee C; Bernhard S; De Santis M
    Lancet Oncol; 2024 Jan; 25(1):46-61. PubMed ID: 38101431
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Adolescent dietary patterns in relation to later prostate cancer risk and mortality in the NIH-AARP Diet and Health Study.
    Lan T; Park Y; Colditz GA; Liu J; Wang M; Wu K; Giovannucci E; Sutcliffe S
    Br J Cancer; 2023 Jan; 128(1):57-62. PubMed ID: 36316560
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Adolescent Plant Product Intake in Relation to Later prostate cancer Risk and Mortality in the NIH-AARP Diet and Health Study.
    Lan T; Park Y; Colditz GA; Liu J; Wang M; Wu K; Giovannucci E; Sutcliffe S
    J Nutr; 2021 Oct; 151(10):3223-3231. PubMed ID: 34383904
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Adolescent animal product intake in relation to later prostate cancer risk and mortality in the NIH-AARP Diet and Health Study.
    Lan T; Park Y; Colditz GA; Liu J; Sinha R; Wang M; Wu K; Giovannucci E; Sutcliffe S
    Br J Cancer; 2021 Oct; 125(8):1158-1167. PubMed ID: 34135472
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Risk of diabetes mellitus in patients with prostate cancer receiving injection therapy: A nationwide population-based propensity score-matched study.
    Lin SY; Lin CL; Chang SS; Chang YH; Hsu WH; Lin CC; Kao CH
    Int J Clin Pract; 2021 Sep; 75(9):e14416. PubMed ID: 34047432
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A Systematic Review of the Evidence for the Decipher Genomic Classifier in prostate cancer.
    Jairath NK; Dal Pra A; Vince R; Dess RT; Jackson WC; Tosoian JJ; McBride SM; Zhao SG; Berlin A; Mahal BA; Kishan AU; Den RB; Freedland SJ; Salami SS; Kaffenberger SD; Pollack A; Tran P; Mehra R; Morgan TM; Weiner AB; Mohamad O; Carroll PR; Cooperberg MR; Karnes RJ; Nguyen PL; Michalski JM; Tward JD; Feng FY; Schaeffer EM; Spratt DE
    Eur Urol; 2021 Mar; 79(3):374-383. PubMed ID: 33293078
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Adolescent dairy product and calcium intake in relation to later prostate cancer risk and mortality in the NIH-AARP Diet and Health Study.
    Lan T; Park Y; Colditz GA; Liu J; Wang M; Wu K; Giovannucci E; Sutcliffe S
    Cancer Causes Control; 2020 Oct; 31(10):891-904. PubMed ID: 32743740
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Ages at menarche and menopause, and mortality among postmenopausal women.
    Zhang X; Liu L; Song F; Song Y; Dai H
    Maturitas; 2019 Dec; 130():50-56. PubMed ID: 31706436
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Detection of Individual prostate cancer Foci via Multiparametric Magnetic Resonance Imaging.
    Johnson DC; Raman SS; Mirak SA; Kwan L; Bajgiran AM; Hsu W; Maehara CK; Ahuja P; Faiena I; Pooli A; Salmasi A; Sisk A; Felker ER; Lu DSK; Reiter RE
    Eur Urol; 2019 May; 75(5):712-720. PubMed ID: 30509763
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Treatment in the STAMPEDE era for castrate resistant prostate cancer in the UK: ongoing challenges and underappreciated clinical problems.
    Greasley RU; Turner R; Collins K; Brown J; Bourke L; Rosario DJ
    BMC Cancer; 2018 Jun; 18(1):667. PubMed ID: 29914436
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The
    Scarpa L; Buxbaum S; Kendler D; Fink K; Bektic J; Gruber L; Decristoforo C; Uprimny C; Lukas P; Horninger W; Virgolini I
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):788-800. PubMed ID: 28083690
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Germline HOXB13 p.Gly84Glu mutation and cancer susceptibility: a pooled analysis of 25 epidemiological studies with 145,257 participates.
    Cai Q; Wang X; Li X; Gong R; Guo X; Tang Y; Yang K; Niu Y; Zhao Y
    Oncotarget; 2015 Dec; 6(39):42312-21. PubMed ID: 26517352
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas.
    Tan HL; Haffner MC; Esopi DM; Vaghasia AM; Giannico GA; Ross HM; Ghosh S; Hicks JL; Zheng Q; Sangoi AR; Yegnasubramanian S; Osunkoya AO; De Marzo AM; Epstein JI; Lotan TL
    Mod Pathol; 2015 Mar; 28(3):446-56. PubMed ID: 25216229
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Obesity is associated with higher risk of prostate cancer detection in a biopsy population in Korea.
    Park J; Cho SY; Lee SB; Son H; Jeong H
    BJU Int; 2014 Dec; 114(6):891-5. PubMed ID: 24314095
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types.
    Giacomini CP; Sun S; Varma S; Shain AH; Giacomini MM; Balagtas J; Sweeney RT; Lai E; Del Vecchio CA; Forster AD; Clarke N; Montgomery KD; Zhu S; Wong AJ; van de Rijn M; West RB; Pollack JR
    PLoS Genet; 2013 Apr; 9(4):e1003464. PubMed ID: 23637631
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Morbidity of focal therapy in the treatment of localized prostate cancer.
    Barret E; Ahallal Y; Sanchez-Salas R; Galiano M; Cosset JM; Validire P; Macek P; Durand M; Prapotnich D; Rozet F; Cathelineau X
    Eur Urol; 2013 Apr; 63(4):618-22. PubMed ID: 23265382
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Low prostate-specific antigen and no Gleason score upgrade despite more extensive cancer during active surveillance predicts insignificant prostate cancer at radical prostatectomy.
    Han JS; Toll AD; Amin A; Carter HB; Landis P; Lee S; Epstein JI
    Urology; 2012 Oct; 80(4):883-8. PubMed ID: 22921697
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials.
    Nguyen PL; Je Y; Schutz FA; Hoffman KE; Hu JC; Parekh A; Beckman JA; Choueiri TK
    JAMA; 2011 Dec; 306(21):2359-66. PubMed ID: 22147380
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.